Timber Pharmaceuticals, Inc.
TMBR
TMBR was delisted on the 28th of November, 2023.
7 hedge funds and large institutions have $6.39M invested in Timber Pharmaceuticals, Inc. in 2015 Q4 according to their latest regulatory filings, with 6 funds opening new positions, increasing their positions, reducing their positions, and 2 closing their positions.
1,342% more capital invested
Capital invested by funds: $443K → $6.39M (+$5.94M)
200% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 2
133% more funds holding
Funds holding: 3 → 7 (+4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
+$5.16M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$56.7K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$37.8K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$18.9K |
| 5 |
LPL Financial
San Diego,
California
|
+$18.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$36K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$18.9K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$5K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Franklin Resources
San Mateo,
California
| $5.63M | +$5.16M | +273 | New |
|
|
RI
2
RTW Investments
New York
| $563K | – | – | – |
|
|
3
Vanguard Group
Malvern,
Pennsylvania
| $78K | +$56.7K | +3 | New |
|
|
4
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $48K | +$37.8K | +2 | New |
|
|
5
LPL Financial
San Diego,
California
| $28K | +$18.9K | +1 | New |
|
|
6
Citadel Advisors
Miami,
Florida
| $19K | +$18.9K | +1 | New |
|
7
Nomura Holdings
Tokyo,
Japan
| $16K | +$18.9K | +1 | New |
|
|
8
UBS Group
Zurich,
Switzerland
| $2K | -$18.9K | -1 | Closed |
|
|
BFA
9
BlackRock Fund Advisors
San Francisco,
California
| $2K | – | – | – |
|
10
Citigroup
New York
| $1K | – | – | – |
|
|
11
Millennium Management
New York
| – | -$36K | -2 | Closed |
|
|
12
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$5K | – | – |
|
TMBR Hedge Fund Activity: Q4 2015 in Review
7 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Timber Pharmaceuticals, Inc. (TMBR) for Q4 2015, worth a combined $6.39M — up 1,342% from $443K a quarter earlier.
Buyers outnumbered sellers: 6 funds opened new TMBR positions and 2 closed out — a net gain of 4 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Franklin Resources, opening a new position worth an estimated $5.16M. The largest seller was Millennium Management, exiting entirely with an estimated $36K sold.
- 7 institutional investors held Timber Pharmaceuticals, Inc. (TMBR) as of Q4 2015, up from 3 in Q3 2015.
- Funds reported $6.39M of Timber Pharmaceuticals, Inc. stock for Q4 2015, up 1,342% quarter-over-quarter.
- 6 funds opened new Timber Pharmaceuticals, Inc. positions in Q4 2015 and 2 closed out, a net change of +4 holders.
- The largest Timber Pharmaceuticals, Inc. buyer in Q4 2015 was Franklin Resources, an estimated $5.16M added.
- The largest Timber Pharmaceuticals, Inc. seller in Q4 2015 was Millennium Management, an estimated $36K sold.
Based on aggregated 13F filings for Q4 2015.